Regulation of ionotropic glutamate receptor subunits in different rat brain areas by a preferential sigma1 receptor ligand and potential atypical antipsychotic

被引:22
作者
Guitart, X [1 ]
Méndez, R [1 ]
Ovalle, S [1 ]
Andreu, F [1 ]
Carceller, A [1 ]
Farré, AJ [1 ]
Zamanillo, D [1 ]
机构
[1] Laboratoris Esteve SA, Res Ctr, Dept Neuropharmacol, Barcelona 08041, Spain
关键词
schizophrenia; antipsychotic; NMDA receptor; AMPA receptor; protein regulation; sigma receptor;
D O I
10.1016/S0893-133X(00)00142-1
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The effect of chronic administration of the putative atypical antipsychotic E-5842, a preferential sigma(1) receptor ligand, on ionotropic glutamate receptor subunit levels of mRNA and protein, was studies. The repeated administration of E-5842 differentially regulated levels of the NMDA-2A and of GluR2 subunits in a regionally specific way. Levels of immunoreactivity for the NMDA-2A subunit were upregulated in the medical prefrontal cortex, the frontoparietal cortex, the cingulate cortex, and in the dorsal striatum, while they were down-regulated in the nucleus accumbens. Levels of the GluR2 subunit of the AMPA receptors were up-regulated in the medial prefrontal cortex and the nucleus accumbens and down-regulation was observed in the dorso-lateral striatum. Regulation of the levels of mRNA for the different subunits was also observed in some cases. The results show that E-5842, through a mechanisms still unknown, is able to modify levels of several glutamate receptor subunits and these changes could be related to its antipsychotic activity in preclinical tests. (C) American College of Neuropsychopharmacology. Published by Elsevier Science Inc.
引用
收藏
页码:539 / 546
页数:8
相关论文
共 40 条
[1]  
Akbarian S, 1996, J NEUROSCI, V16, P19
[2]   RECEPTOR ACTIVITY AND TURNOVER OF DOPAMINE AND NORADRENALINE AFTER NEUROLEPTICS [J].
ANDEN, NE ;
BUTCHER, SG ;
CORRODI, H ;
FUXE, K ;
UNGERSTEDT, U .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1970, 11 (03) :303-+
[3]   AMPHETAMINE PSYCHOSIS - BEHAVIORAL AND BIOCHEMICAL ASPECTS [J].
ANGRIST, B ;
SATHANANTHAN, G ;
WILK, S ;
GERSHON, S .
JOURNAL OF PSYCHIATRIC RESEARCH, 1974, 11 :13-23
[4]   INTERACTIONS BETWEEN GLUTAMATERGIC AND MONOAMINERGIC SYSTEMS WITHIN THE BASAL GANGLIA - IMPLICATIONS FOR SCHIZOPHRENIA AND PARKINSONS-DISEASE [J].
CARLSSON, M ;
CARLSSON, A .
TRENDS IN NEUROSCIENCES, 1990, 13 (07) :272-276
[5]   DOPAMINE RECEPTOR-BINDING PREDICTS CLINICAL AND PHARMACOLOGICAL POTENCIES OF ANTI-SCHIZOPHRENIC DRUGS [J].
CREESE, I ;
BURT, DR ;
SNYDER, SH .
SCIENCE, 1976, 192 (4238) :481-483
[6]  
DAVIS KL, 1991, AM J PSYCHIAT, V148, P1474
[7]   A GLUTAMATERGIC HYPOTHESIS OF SCHIZOPHRENIA - RATIONALE FOR PHARMACOTHERAPY WITH GLYCINE [J].
DEUTSCH, SI ;
MASTROPAOLO, J ;
SCHWARTZ, BL ;
ROSSE, RB ;
MORIHISA, JM .
CLINICAL NEUROPHARMACOLOGY, 1989, 12 (01) :1-13
[8]   DEVELOPMENTAL REGULATION OF MESSENGER-RNAS ENCODING RAT-BRAIN KAINATE AMPA RECEPTORS - A NORTHERN ANALYSIS STUDY [J].
DURAND, GM ;
ZUKIN, RS .
JOURNAL OF NEUROCHEMISTRY, 1993, 61 (06) :2239-2246
[9]   THE N-METHYL-D-ASPARTATE ANTAGONISTS PHENCYCLIDINE, KETAMINE AND DIZOCILPINE AS BOTH BEHAVIORAL AND ANATOMICAL MODELS OF THE DEMENTIAS [J].
ELLISON, G .
BRAIN RESEARCH REVIEWS, 1995, 20 (02) :250-267
[10]   REGULATION OF CORTICAL AND SUBCORTICAL GLUTAMATE-RECEPTOR SUBUNIT EXPRESSION BY ANTIPSYCHOTIC-DRUGS [J].
FITZGERALD, LW ;
DEUTCH, AY ;
GASIC, G ;
HEINEMANN, SF ;
NESTLER, EJ .
JOURNAL OF NEUROSCIENCE, 1995, 15 (03) :2453-2461